Landmark®

Inhalers, Metered Dose Inhalers
Pharmaceutical, Inhalation

Aptar Pharma’s FDA compliant Landmark® dose counting device is compatible with all types of pMDIs including nasal actuators. It features an easy to read color-coded numeric display, which informs the patient of the number of doses remaining within the pMDI, helping to improve their compliance. Landmark® has several market references in the US, Asia and Europe.

mockup with visible interior and exterior structure of metered dose inhaler
mockup with visible interior and exterior structure of metered dose inhaler
view of a metered dose inhaler with dose counter

A Landmark® in Mechanical Dose

Counters

Landmark-Color-Code_2-scaled.jpg

The reference dose indicator with color and numeric display

This intuitive, easy to use, robust, dose indicator technology is FDA compliant, with an RGB color and numeric indicator to show the remaining dose available, thus helping to improve patient compliance. Landmark has multiple market references in the US, Asia and Europe.

Proprietary Dose Counter and compatible with all metering valves

Landmark is supported by a strong patent portfolio and is designed to be compatible with all types of metering valves used in pMDIs for both pulmonary and nasal applications, for both solution and suspension based formulations.

close_up_inhaler.jpg

We offer complete solutions

As a Global leader in pulmonary drug delivery device solutions, our devices are often considered “the Gold standard” in the management of asthma and COPD.

We have proven expertise in device design and formulation development through the clinical trial phases, analytical testing and regulatory filings and market launches. We add value at every stage of the drug development process, accelerating and derisking programs along the way.

We understand metering valves and dose counter technologies with active formulations, so we can ensure the compatibility of Landmark with other elements of your pMDI product.

Design and development with state of the art science

In Aptar Pharma, we have a culture of Innovation Excellence. Our R&D teams work with thought leaders globally to design, develop and deliver optimal asthma solutions, driven by patient preference. We also co-sponsor and co-organise Respiratory conferences including RDD Europe, showing our continued investment in respiratory conditions.

Landmark® Advantages

 

We Have a Broad Range of Value Added Services to Accelerate and Derisk
Your Drug Product Development.

Start a Project With Us

We Thrive on Transforming Ideas into Opportunities – Let Yours be Next.

We Offer World-Leading Support Services for You at Every Stage of Your Product Development

Explore How We Serve Your Market